Cxcl14, a CXCR4-inhibitory ligand, localized to the outer tumor margins, whereas Cxcl16, a CXCR6 ligand important for effector T cells and ILC2s, was enriched in the tumor core (Fig. 3a). The gene discussed is CXCL16; the disease is neoplasm.